Abstract
INTRODUCTION
Clinical pharmacists are an essential part of the health care team, especially because they promote the safe and rational use of medications [1] . The typical role of clinical pharmacists involves ensuring appropriate prescription/therapeutic combinations and administration of the right medicine to the right patient in the appropriate dose via the proper route of administration. Other essential responsibilities of the clinical pharmacist are to monitor patient adherence to therapy, provide drug information, monitor patient responses and laboratory values, and provide patient and provider education. In increasing patients' adherence to therapy, clinical pharmacists simultaneously decrease the chances of drug-related problems, and in doing so, the patient's quality of life is enhanced and further economic burdens due to drug-related problems are lessened [2] .
However, clinical pharmacists seldom play an effective role in the emergency department (ED) of Public Hospital, Al-Ahsa, Eastern Region, Saudi Arabia [2] . This may be due to the unique and complex nature of the ED. EDs in hospital settings are known to be high risk environments, with frequent emergency errors [3] . According to the findings of the U.S. Institute of Medicine, ED has the highest rate of preventable adverse events [4] . In the U.S., ED care is available to approximately 110 million patients per year [5] . Of these, 5.5 million (5 %) experience adverse drug events [6] . Studies have shown that 70 % (3.8 million) of these adverse drug events can be prevented through proper screening while administering and prescribing drugs to patients attending EDs [7] . Published reports on the incorporation of clinical pharmacists in the ED have shown a marked decline in the number of preventable iatrogenic errors with patients [8] .
Al-Olah and Al Thiab reported a high incidence of drug related problems (DRPs) in the ED of a public hospital in Riyadh, Saudi Arabia. Over a duration of one month, approximately 557 patients visited the ED and 82 (14.7 %) of the patients experienced a DRP [9] . Admission to ED was mainly due to failure to take medications (47.2 %), followed by adverse drug reactions (24.5 %) and drug overdose (11.3 %). The most common drugs associated with DRPs were insulin, antiasthmatics, chemotherapeutic agents, warfarin, oral hypoglycemic and antihypertensive agents [9] .
In Saudi Arabia, clinical pharmacy practice is in the process of being instituted in many public and private hospitals. In most of such hospitals, individuals with Bachelor of Pharmacy (B.Pharm) degree holders are engaged in conventional pharmacy practice; however, Pharm-Ds, who trained in direct patient care have recently been joining the services of these hospitals. At the moment, no hospital in the eastern region of Saudi Arabia, or perhaps in the country as a whole, has engaged a clinical pharmacist in a patient care unit, especially the ED. This study aims to evaluate the attitudes and perceptions of medical doctors and nurses in ED about the role of the clinical pharmacist.
METHODS
A pilot study was conducted among the medical and paramedical staff at the Emergency Department (ED), Public Hospital, Al-Ahsa, Eastern Region, Saudi Arabia,. The duration of this study was from 1 st July to 20 th August 2010. The entire medical and paramedical staff in the ED were invited to participate in the study.
Study instrument
A self-developed 24-item questionnaire was used to assess the objectives of the study. The questionnaire was designed in line with that of previous studies conducted in this regard in other Arab countries, such as Kuwait [10] . The content validity of the questionnaire was established by professionals at the College of Clinical Pharmacy, King Faisal University, and the Departments of Public Health and Biostatistics, Public Hospital, Eastern Region, Al-Ahsa. Face validity was tested on ten respondents from the nursing school, Public Hospital, Eastern Region, Al-Ahsa. A reliability scale was applied and the internal consistency of the questionnaire was measured using Cronbach's Alpha which gave a value of 0.58. The questionnaire had four sections. The first section consisted of nine items that mainly focused on the demographic information of the respondents, their experience and current position in the hospital. Section two explored medical and paramedical staff knowledge about Pharm-D degree and clinical pharmacy. Five questions were included in this section and they assessed the respondents' awareness of the Pharm-D degree and the professional practice of clinical pharmacy. This section also inquired about the availability of a clinical pharmacist in the respondents' hospital and whether a clinical pharmacist is the same as a hospital pharmacist. Section three mainly explored the level of interaction between the ED staff and the pharmacist. Respondents were asked how often they interacted with the pharmacist in the hospital setting and the reason for such interaction. The last section assessed ED staff's attitude toward the role of clinical pharmacists in EDs. Eight subitems were included in this section, and a three-item Likert scale (Agree, Disagree, Don't Want to Disclose) was used to measure the response.
Ethical considerations
A written consent was obtained from the respondents for their participation; furthermore, formal permission to conduct this study was requested from the head of the ED. Any questions that might disclose the identity of any respondents were avoided.
Data analysis
All the responses were coded, and descriptive statistics were applied using the Statistical Package for Social Science Students (SPSS 13) ® .
RESULTS
A total of 20 individuals present at ED during the study period were approached for their potential participation in this study. Of these, 16 expressed willingness to participate in the study, producing a response rate of 80.0 %. Six (37.5 %) of the respondents were doctors and the rest were nursing staff. The mean age (years) of the respondents was 37.0 (SD ± 7.1, range 24 -47 years).The majority of the respondents were foreign nationals. Detailed information about the respondents are listed in Table 1 . For the second item respondents gave multiple responses and so the sum will not be 100 %
Information about Pharm-D program and clinical pharmacist
Ten (62.5 %) members of the ED staff were aware of the professional Pharm-D degree, and 12 (75.0 %) disclosed that they had heard of a clinical pharmacist. A majority, i.e., 10 (62.5 %) affirmed that they have heard of clinical pharmacy from a friend or medical journal, while 6 (37.5 %) noted that they had worked with a clinical pharmacist. ED staff responses about the availability of a clinical pharmacist at their hospital and their perceptions of the differences between clinical pharmacy and hospital pharmacy are shown in Table 2 Level of interaction with pharmacists Table 3 indicates that most of the respondents disclosed that they interacted with pharmacists only in the case of emergencies. Further exploration revealed that pharmacists are mostly consulted to discuss drug dosages and routes of administration.
Medical staff attitudes toward the availability and possible role of clinical pharmacist in EDs
Overall, a positive attitude towards the availability of the clinical pharmacist in ED was seen. The majority, i.e., 13 (81.3 %) of 
DISCUSSION
the medical and nursing staff agreed that it would be more helpful if clinical pharmacists were available on a full-time basis in the ED, and 10 (62.5 %) agreed that patient care would be improved if the clinical pharmacist worked with medical and nursing staff in ED. On the other hand, half of the respondents (50.0 %) believed that the presence of a pharmacist in ED would somehow interfere with their work. Detailed responses of the staff toward the availability of the clinical pharmacist in ED are shown in Table 4 .
Unlike the handling of medication in the main health care site, medications in the ED are always ordered, dispensed, and administered in a state of urgency for a patient at risk. Most of the medication orders given in such a situation are verbal because of the nature of ED, including the need for immediate medical care [11] . Handling a case in ED is a challenge because, in most cases, physicians are not aware of the patient's complete medical information and the medicines are dispensed directly to the patient without any prescription review [11] . Due to the high-alert environment of ED, health care staff members frequently handle multiple patients; the lack of review of prescriptions [11] can result in the potential risk of a mix-up of certain IV fluids, inotropic agents, and sedatives [8] which, in turn, can cause adverse events that may be fatal. Often, these adverse events are not reported because of the lack of follow-up for ED patients. Too often, if an adverse event is highlighted or reported, then the health provider -not the system -is blamed [12] .
Considerations given to designing a system that improves patient safety [13] may well avert or reduce many adverse events before they reach the patient [14, 15] . An ideal health care system removes the flaws or gaps that give rise to errors; if an error occurs nevertheless, it should be detected before it reaches the patient [15] . Incorporating the role of the clinical pharmacist in ED or other health care settings can reduce the number of adverse events, as research has shown [16] . Despite this demonstrated improvement in patient care along with cost savings [17] , the role of the clinical pharmacist is not yet well-accepted in the hospital setting [18] . A possible reason for this attitude may the limited interaction of nursing staff with pharmacists because they do not consider pharmacists to be adequately trained to participate in patient care [18] .
Medical and nursing staff's perception of the role of the clinical pharmacist in ED in the present study is worthy of review. A majority of our respondents were willing to accept the availability of a full-time clinical pharmacist in ED and more than half agreed with the statement that clinical pharmacist involvement in the health care team at ED would be helpful in patient care. However, some respondents had differing opinions. A possible reason for this negative attitude is that these staff perceive that the pharmacist will complicate or interfere with their work. These findings are in agreement with findings elsewhere which also indicate there are barriers to the acceptance of the pharmacist in the health care team by nurses and physicians [18, 19] .
Furthermore, the ED staff response on the role of the pharmacist in drug adherence by patients was moderate. Nearly half agreed that adherence to drug therapy would be improved if the pharmacist is involved in direct patient care, but a majority disagreed with giving prescription rights to clinical pharmacists even when only minor ailments are involved. The reason for this attitude is a potential issue for the future research in the region. Our finding in this regard is similar to those of Matowe et al who also reported physician reluctance to give prescription rights to pharmacists even when minor ailments are involved [10] .
Our findings highlight the need for the Ministry of Health in Saudi Arabia to take the initiative to intervene to develop an environment where physicians and pharmacists can work closely [19] . Other ED staff members need an opportunity to observe the pharmacist effectively acting as a part of the patient care team to enable them appreciate the very important roles that pharmacists are capable of playing in ED [10] .
Limitations of the study
The current study lacks sufficient information to firmly establish the reasons for different attitudes of medical staff members toward pharmacists' possible role in direct patient care. The probable reason may be the absence of a clinical pharmacist at the ER department, thus limiting interactions with other ED staff and reducing awareness of the potential role of clinical pharmacists in direct patient care [18, 19] .
CONCLUSION
The findings of this study highlight the need to enhance the interaction between the medical and paramedical staff, on the one hand, and clinical pharmacists, on the other, in order to facilitate the participation of the clinical pharmacist in direct patient care. If this is not done now, the first generation of Doctor of Pharmacy (Pharm-D) graduates that are expected to emerge in Saudi Arabia in the near future will face tremendous challenges in their practice within the Saudi health care system.
